Share of Piramal Enterprises Limited is currently trading at around Rs.826/-Existing as well as Prospective Investors are asking for Piramal Enterprises Share Price Targets for 2024,2025,2030,2035 & 2040. In this article, we will discuss about the business prospects and financial performance of the Company and based on our discussion and analysis will tell you the Piramal Enterprises Share Price Target from 2024 to 2040.
Discussion & Analysis of Business & Financial performance with future business prospects of Piramal Enterprises Ltd:
Piramal Enterprises Ltd (PEL), a diversified Indian conglomerate, has demonstrated resilient business performance in recent years and shows promising prospects for the future. The company operates mainly through its three key verticals: financial services, pharmaceuticals, and healthcare insights & analytics.
Current Business Performance
Financial Services: PEL’s financial services segment has been a robust performer. This division includes wholesale lending, retail lending, and alternative asset management. In the retail lending space, the company has expanded its housing finance portfolio significantly, capitalizing on the growing demand for affordable housing in India. The wholesale lending business, which focuses on real estate and corporate lending, has also seen growth, though it remains cautious due to the overall economic climate and non-performing asset concerns in the broader financial sector.
Pharmaceuticals: The pharmaceuticals segment, under Piramal Pharma Solutions (PPS), includes contract development and manufacturing, critical care, and consumer products. The contract development and manufacturing organization (CDMO) business has benefited from increased outsourcing by global pharmaceutical companies. Piramal Critical Care has also expanded its product portfolio and geographic reach. The consumer healthcare business, which includes over-the-counter products, has shown steady growth driven by strong brand recognition and an expanding product range.
Healthcare Insights & Analytics: This relatively newer vertical, focusing on providing data and analytics solutions to the healthcare industry, has shown promising potential. The acquisition of Decision Resources Group (DRG) has bolstered this segment, enabling PEL to offer a comprehensive suite of solutions to pharmaceutical and healthcare companies worldwide.
Future Business Prospects
Expansion in Financial Services: The future looks bright for PEL’s financial services segment, especially with the planned demerger of its pharmaceuticals business, which will allow it to focus more on financial services. The retail lending business is expected to grow as India’s economy rebounds and consumer confidence improves. PEL’s strategy to increase its presence in affordable housing and expand its digital lending platform could drive significant growth. Moreover, the company’s cautious approach towards wholesale lending, with a focus on asset quality, should help mitigate risks.
Growth in Pharmaceuticals: Post-demerger, Piramal Pharma Solutions will be positioned as an independent entity, potentially enhancing its growth prospects. The global trend towards increased outsourcing by pharma companies is likely to benefit PPS. The company’s investments in capacity expansion, technology upgrades, and broadening its product portfolio should yield long-term benefits. The critical care segment’s growth will be supported by the rising demand for hospital infrastructure and services globally.
Healthcare Insights & Analytics: This segment is expected to grow as the healthcare industry increasingly relies on data and analytics for decision-making. PEL’s investment in building a robust analytics platform and expanding its service offerings will cater to the growing demand from pharmaceutical companies looking to optimize their research and marketing strategies.
Strategic Initiatives: PEL has consistently focused on strategic initiatives such as demergers and acquisitions to streamline operations and enhance shareholder value. The planned demerger of the pharmaceuticals business is aimed at unlocking value and providing focused growth opportunities for both entities. Additionally, PEL’s prudent financial management, including deleveraging and maintaining a strong balance sheet, positions it well to capitalize on future growth opportunities.
Challenges and Mitigating Factors
While the prospects are promising, PEL does face challenges such as regulatory changes, market competition, and economic uncertainties. However, its diversified business model, strong management team, and strategic initiatives aimed at focusing on core strengths and leveraging market opportunities provide a solid foundation for future growth.
Conclusion
In summary, Piramal Enterprises Ltd is well-positioned for sustained growth across its business verticals. With strategic focus and operational efficiency, PEL is likely to continue delivering strong performance and enhancing shareholder value in the coming years.
Top of Form
Share Price Targets:
Piramal Enterprises Share Price Target 2024
Based on the above discussion and analysis, the share price of Piramal Enterprises is likely to touch the level of around Rs.900-910 in 2024
Piramal Enterprises Share Price Target 2025
Based on the above discussion and analysis, the share price of Piramal Enterprises is likely to touch the level of around Rs.1000-1025 in 2025
Piramal Enterprises Share Price Target 2030
Based on the above discussion and analysis, the share price of Piramal Enterprises is likely to touch the level of around Rs.1575-1600 in 2030
Piramal Enterprises Share Price Target 2035
Based on the above discussion and analysis, the share price of Piramal Enterprises is likely to touch the level of around Rs.2475-2500 in 2035
Piramal Enterprises Share Price Target 2040
Based on the above discussion and analysis, the share price of Piramal Enterprises is likely to touch the level of around Rs.3775-4000 in 2040
Disclaimer: Investment in Capital Market/Share Prices are subject to market fluctuations and are dependent on several factors. These predictions are based on the current market conditions and the future market expectations. Investors are advised to take into consideration all these factors before making any investment in Capital Market. This article should not be treated as Investment advisory and is for general Guidance & Educational purpose only. We keep revising our share price targets based on the latest information available with us. Please keep visiting our website regularly to keep yourself updated. MoneyInsight does not offer investment advice and does not encourage any action based on its content.
Read Also:
How to make maximum profit with minimum investment from the Stock Market ? – MoneyInsight
Also Read :
How to make money from share market? (indiatimes.com)
Visit our Website regularly for more such Educational Research Articles:
MoneyInsight – We Provide Insight to Your Money
